<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Parry, Nicola</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Spaulding, Christian</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Improved Outcomes in Cardiogenic Shock</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">6-7</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses the epidemiology of ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock, and its association with the increasing use of reperfusion therapy, especially primary percutaneous coronary intervention (PCI). Specific topics include reperfusion therapy, cardiac assist devices, shock after resuscitated cardiac arrest, and the use of PCI in refractory in- or out-of-hospital cardiac arrest.</style></abstract><number><style face="normal" font="default" size="100%">7</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>